Your browser doesn't support javascript.
loading
Osteoblasts secrete miRNA-containing extracellular vesicles that enhance expansion of human umbilical cord blood cells.
Morhayim, Jess; van de Peppel, Jeroen; Braakman, Eric; Rombouts, Elwin W J C; Ter Borg, Mariette N D; Dudakovic, Amel; Chiba, Hideki; van der Eerden, Bram C J; Raaijmakers, Marc H; van Wijnen, Andre J; Cornelissen, Jan J; van Leeuwen, Johannes P.
Affiliation
  • Morhayim J; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van de Peppel J; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Braakman E; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Rombouts EW; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Ter Borg MN; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Dudakovic A; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Chiba H; Fukushima Medical University School of Medicine, Hikarigaoka, 960-1295, Fukushima, Japan.
  • van der Eerden BC; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Raaijmakers MH; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Wijnen AJ; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
  • Cornelissen JJ; Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • van Leeuwen JP; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Sci Rep ; 6: 32034, 2016 09 02.
Article in En | MEDLINE | ID: mdl-27585950
ABSTRACT
Osteolineage cells represent one of the critical bone marrow niche components that support maintenance of hematopoietic stem and progenitor cells (HSPCs). Recent studies demonstrate that extracellular vesicles (EVs) regulate stem cell development via horizontal transfer of bioactive cargo, including microRNAs (miRNAs). Using next-generation sequencing we show that human osteoblast-derived EVs contain highly abundant miRNAs specifically enriched in EVs, including critical regulators of hematopoietic proliferation (e.g., miR-29a). EV treatment of human umbilical cord blood-derived CD34(+) HSPCs alters the expression of candidate miRNA targets, such as HBP1, BCL2 and PTEN. Furthermore, EVs enhance proliferation of CD34(+) cells and their immature subsets in growth factor-driven ex vivo expansion cultures. Importantly, EV-expanded cells retain their differentiation capacity in vitro and successfully engraft in vivo. These discoveries reveal a novel osteoblast-derived EV-mediated mechanism for regulation of HSPC proliferation and warrant consideration of EV-miRNAs for the development of expansion strategies to treat hematological disorders.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Hematopoietic Stem Cells / MicroRNAs / Fetal Blood / Extracellular Vesicles Limits: Animals / Female / Humans Language: En Journal: Sci Rep Year: 2016 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteoblasts / Hematopoietic Stem Cells / MicroRNAs / Fetal Blood / Extracellular Vesicles Limits: Animals / Female / Humans Language: En Journal: Sci Rep Year: 2016 Document type: Article Affiliation country: Netherlands